User profiles for Outi M. Keinänen

Outi Keinänen

Assistant Professor, University of Alabama at Birmingham (UAB)
Verified email at uab.edu
Cited by 617

Molecular Imaging, Radiochemistry, and Environmental Pollutants

…, J Sebastiano, BM Zeglis, OM Keinänen - Journal of Nuclear …, 2023 - Soc Nuclear Med
The worldwide proliferation of persistent environmental pollutants is accelerating at an alarming
rate. Not surprisingly, many of these pollutants pose a risk to human health. In this review…

Toward the optimization of click-mediated pretargeted radioimmunotherapy

R Membreno, OM Keinänen, BE Cook… - Molecular …, 2019 - ACS Publications
Pretargeted radioimmunotherapy (PRIT) based on the inverse electron demand Diels–Alder
reaction has shown promise in murine models of disease, yet the radiation dosimetry of this …

Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer

…, A Santos-Coquillat, OM Keinänen… - Molecular …, 2024 - ACS Publications
Despite decades of work, small-cell lung cancer (SCLC) remains a frustratingly recalcitrant
disease. Both diagnosis and treatment are challenges: low-dose computed tomography (the …

Antibody engineering for nuclear imaging and radioimmunotherapy

…, S Delaney, SM Sarrett, OM Keinänen… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Radiolabeled antibodies have become indispensable tools in nuclear medicine. However,
the natural roles of antibodies within the immune system mean that they have several intrinsic …

Inverse electron demand Diels–Alder click chemistry for pretargeted PET imaging and radioimmunotherapy

SM Sarrett, O Keinänen, EJ Dayts, G Dewaele-Le Roi… - Nature protocols, 2021 - nature.com
Radiolabeled antibodies have shown promise as tools for both the nuclear imaging and
endoradiotherapy of cancer, but the protracted circulation time of radioimmunoconjugates can …

Pretargeted Radiopharmaceutical Therapy

OM Keinänen, BM Zeglis - Radiopharmaceutical Therapy, 2023 - Springer
Radioimmunotherapy (RIT) has long stood as a promising approach to radiopharmaceutical
therapy (RPT). However, the relatively slow pharmacokinetic profile of full-length …

Removal of Fc Glycans from [89Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8+ T Cells

JM White, OM Keinänen, BE Cook… - Molecular …, 2020 - ACS Publications
The N-linked biantennary glycans on the heavy chain of immunoglobulin G (IgG) antibodies
(mAbs) are instrumental in the recognition of the Fc region by Fc-gamma receptors (FcγR). …

[HTML][HTML] Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models

O Keinänen, K Fung, J Pourat, V Jallinoja, D Vivier… - EJNMMI research, 2017 - Springer
Background Pretargeting-based approaches are being investigated for radioimmunoimaging
and therapy applications to reduce the effective radiation burden to the patient. To date, …

[HTML][HTML] Harnessing PET to track micro-and nanoplastics in vivo

O Keinänen, EJ Dayts, C Rodriguez, SM Sarrett… - Scientific reports, 2021 - nature.com
The proliferation of plastics in the environment continues at an alarming rate. Plastic particles
have been found to be persistent and ubiquitous pollutants in a variety of environments, …

Dual radionuclide theranostic pretargeting

O Keinänen, JM Brennan, R Membreno… - Molecular …, 2019 - ACS Publications
Recent years have played witness to the advent of nuclear theranostics: the synergistic use
of “matched pair” radiopharmaceuticals for diagnostic imaging and targeted radiotherapy. In …